Two University of Mississippi Medical Center researchers were awarded a patent that could revolutionize how cancer drugs are delivered. The new approach is one that could cut down on the number of chemotherapy treatments required, a measure that could save patients from some of the side effects that come with the aggressive treatment.
Additionally, the change in delivering the drugs could allow treatment for certain cancers that currently aren’t viable for chemotherapy.